Gilead Sciences Inc
SWB:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
SWB:GIS
|
US |
|
Orange SA
F:FTE
|
FR |
|
M
|
M&T Bank Corp
DUS:MTZ
|
US |
|
Intellego Technologies AB
F:7RW
|
SE |
|
Kuaishou Technology
F:5Y0
|
CN |
|
I
|
Industria de Diseno Textil SA
MIL:ITX
|
ES |
|
Caixabank SA
OTC:CAIXY
|
ES |
|
C
|
CVC Capital Partners PLC
AEX:CVC
|
JE |
|
Old Mutual Ltd
F:2KS
|
ZA |
|
Getlink SE
PAR:GET
|
FR |
|
G
|
General Electric Co
LSE:GEC
|
US |
|
I
|
IWG Plc
OTC:IWGFF
|
CH |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for
GIS is 140.19 EUR with a low forecast of 105.66 EUR and a high forecast of 164.77 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
140.19
EUR
According to Wall Street analysts, the average 1-year price target for
GIS is 140.19 EUR with a low forecast of 105.66 EUR and a high forecast of 164.77 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.